What is the cause of thyroiditis in a 14‑month postpartum woman taking lithium therapy?

Cause of Thyroiditis in a 14-Month Postpartum Patient Taking Lithium

The most likely cause is postpartum thyroiditis, with lithium potentially exacerbating or unmasking the condition through its immunomodulatory effects on an already autoimmune-susceptible thyroid gland.

Understanding the Dual Etiology

Postpartum Thyroiditis as the Primary Driver

Postpartum thyroiditis is diagnosed by new onset of abnormal TSH levels, abnormal free T4 levels, or both, with antibody testing useful in confirming the diagnosis 1. At 14 months postpartum, this patient remains within the typical timeframe for postpartum thyroid dysfunction, which can manifest up to 12-18 months after delivery.

The condition represents an autoimmune phenomenon where:

• The postpartum period triggers thyroid autoimmunity in susceptible women 1
• Anti-thyroid peroxidase (anti-TPO) antibodies are frequently present 1
• The risk of permanent hypothyroidism is greatest in women with the highest levels of TSH and antithyroid peroxidase antibodies 1

Lithium's Contributory Role

Lithium affects thyroid function through multiple mechanisms and can induce autoimmune thyroiditis by acting as a hapten with thyroid antigens 2. The drug's specific effects include:

• Direct thyroid suppression: Lithium decreases thyroid hormone synthesis and release at the cellular level 3
• Peripheral effects: It decreases peripheral deiodination of T4 by reducing type I 5' deiodinase enzyme activity 3
• Autoimmune augmentation: Lithium increases propensity to thyroid autoimmunity by augmenting B lymphocyte activity and reducing the ratio of circulating suppressor to cytotoxic T cells 3

The histopathologic features of lithium-associated thyroiditis include fibrosis, lymphoid follicles with atrophy, and hyperplasia of thyroid follicles, with the pathogenetic mechanism appearing to be immunologic 2.

Clinical Presentation Pattern

In this 14-month postpartum patient, the thyroiditis likely represents a convergence of two risk factors:

1. Postpartum autoimmune rebound: The immune system suppression during pregnancy reverses postpartum, triggering autoimmune thyroid disease 1
2. Lithium-induced immune dysregulation: Chronic lithium therapy (presumably started for bipolar disorder) creates additional autoimmune susceptibility 3

Distinguishing Features

The combination creates a particularly high-risk scenario because:

• Middle-aged females (≥50 years) on lithium have increased risk of thyroid dysfunction 3
• Patients with family history of thyroid disease are more susceptible 3
• Those positive for thyroid auto-antibodies (anti-TPO and TSH receptor antibodies) require more frequent monitoring 3

Diagnostic Approach

Measure TSH, free T4, and anti-TPO antibodies to confirm the diagnosis and predict risk of permanent hypothyroidism 1, 3. The presence of anti-TPO antibodies would confirm autoimmune etiology and indicate whether lithium has triggered or exacerbated underlying autoimmune thyroiditis 3.

Additional considerations:

• Antimicrosomal antibodies are more commonly detected than antithyroglobulin antibodies in lithium-treated patients 4
• Patients with antithyroglobulin antibodies typically also have antimicrosomal antibodies 4
• Approximately 20% of lithium-treated patients develop antithyroid antibodies 4

Management Implications

Whether treatment is needed depends on the severity of the abnormality and symptoms 1. The evaluation should include:

• Assessment of goiter development during or after pregnancy 1
• Evaluation for symptoms of hyperthyroidism or hypothyroidism, though some symptoms overlap with normal postpartum experiences 1
• Recognition that the risk of permanent hypothyroidism is greatest with highest TSH levels and antithyroid peroxidase antibodies 1

Critical Pitfall to Avoid

Do not assume this is purely lithium-induced thyroiditis—the postpartum timing is crucial. While lithium can cause hypothyroidism, goiter, and rarely hyperthyroidism 3, the 14-month postpartum timeframe strongly suggests postpartum thyroiditis as the primary process, with lithium serving as a cofactor that increased susceptibility through its immunomodulatory effects 2, 3.

Rare but Important Consideration

In exceptional cases, lithium-associated thyrotoxicosis can follow hypothyroidism, representing a biphasic autoimmune process 5. If this patient presents with hyperthyroid symptoms, consider silent thyroiditis with a thyrotoxic phase, which can precipitate lithium toxicity through increased tubular reabsorption of lithium 6.